RadNetRDNT
RDNT
About: RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Employees: 11,021
0
Funds holding %
of 7,245 funds
0
Analysts bullish %
of 3 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
803% more call options, than puts
Call options by funds: $72.4M | Put options by funds: $8.01M
22% more repeat investments, than reductions
Existing positions increased: 123 | Existing positions reduced: 101
5.97% more ownership
Funds ownership: 86.27% [Q4 2024] → 92.24% (+5.97%) [Q1 2025]
7% less funds holding
Funds holding: 325 [Q4 2024] → 301 (-24) [Q1 2025]
24% less capital invested
Capital invested by funds: $4.46B [Q4 2024] → $3.4B (-$1.06B) [Q1 2025]
29% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 65
44% less funds holding in top 10
Funds holding in top 10: 9 [Q4 2024] → 5 (-4) [Q1 2025]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$60
3%
upside
Avg. target
$66
14%
upside
High target
$74
27%
upside
3 analyst ratings
3 positive
100%
0 neutral
0%
0 negative
0%
Truist Securities David Macdonald | 27%upside $74 | Buy Maintained | 11 Apr 2025 |
Barclays Andrew Mok | 3%upside $60 | Overweight Maintained | 24 Mar 2025 |
Raymond James John Ransom | 12%upside $65 | Strong Buy Upgraded | 5 Mar 2025 |
Financial journalist opinion
Based on 5 articles about RDNT published over the past 30 days
Neutral
Seeking Alpha
1 week ago
RadNet, Inc. (RDNT) Q1 2025 Earnings Call Transcript
RadNet, Inc. (NASDAQ:RDNT ) Q1 2025 Earnings Conference Call May 12, 2025 10:30 AM ET Company Participants Mark Stolper - CFO Howard Berger - President and CEO Conference Call Participants Brian Tanquilut - Jefferies Grayson McAlister - Truist Securities Andrew Mok - Barclays Larry Solow - CJS Securities Brandon Carney - B. Riley Operator Good day, and welcome to the RadNet, Inc. First Quarter 2025 Financial Results Conference Call.
Neutral
GlobeNewsWire
1 week ago
RadNet Reports First Quarter Financial Results and Revises Upwards 2025 Financial Guidance Ranges for Revenue and Adjusted EBITDA¹
LOS ANGELES, May 11, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 401 owned and operated outpatient imaging centers, today reported financial results for its first quarter of 2025.
Neutral
GlobeNewsWire
1 week ago
RadNet, Inc. to Present at the Bank of America Securities 2025 Healthcare Conference on May 13th, 2025
LOS ANGELES, May 09, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Financial Officer will be presenting at the Bank of America Securities 2025 Healthcare Conference in Las Vegas, NV on Tuesday, May 13, 2025 at 5:00 p.m. Pacific Time.
Positive
Seeking Alpha
3 weeks ago
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals saw increased investor confidence in its cystic fibrosis franchise and evolving pipeline, including promising non-opioid pain treatments and kidney disease drugs. UnitedHealth Group's shares gained as 2024 headwinds subsided, Medicare Advantage rates improved, and higher-margin Optum segments grew, insulating it from tariff impacts.
Neutral
GlobeNewsWire
4 weeks ago
RadNet, Inc. Announces Date of its First Quarter 2025 Financial Results Conference Call
LOS ANGELES, April 24, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its first quarter 2025 financial results on Monday, May 12, 2025 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Neutral
Business Wire
1 month ago
ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of iCAD, Inc. (NasdaqCM: ICAD) to RadNet, Inc. (NasdaqGM: RDNT). Under the terms of the proposed transaction, shareholders of iCAD will receive 0.0677 shares of RadNet for each share of iCAD that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequat.
Neutral
GlobeNewsWire
1 month ago
RadNet, Inc. to Acquire iCAD, Inc. to Accelerate AI-Powered Early Detection and Diagnosis of Breast Cancer
LOS ANGELES and NASHUA, N.H., April 15, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective diagnostic imaging services and digital health solutions, and iCAD, Inc. (NASDAQ: ICAD) (“iCAD”), a global leader in providing clinically proven AI-powered breast health solutions, announced today that they have entered into a definitive merger agreement under which RadNet will acquire iCAD in an all stock transaction.
Positive
Benzinga
2 months ago
Top 3 Health Care Stocks You'll Regret Missing This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Neutral
GlobeNewsWire
2 months ago
RadNet, Inc. to Present at the 35th Annual Oppenheimer Healthcare MedTech & Services Conference March 17th, 2025
LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, Executive Vice President and Chief Executive Officer, will be presenting virtually at the 35th Oppenheimer Healthcare MedTech & Services Conference on Monday, March 17, 2025 at 12:40 p.m. Eastern Time.
Neutral
Seeking Alpha
2 months ago
RadNet, Inc. (RDNT) Q4 2024 Earnings Call Transcript
RadNet, Inc. (NASDAQ:RDNT ) Q4 2024 Earnings Conference Call February 28, 2025 10:30 AM ET Company Participants Mark Stolper - Executive Vice President & Chief Financial Officer Howard Berger - President & Chief Executive Officer Conference Call Participants David MacDonald - Truist Brian Tanquilut - Jefferies John Ransom - Raymond James Andrew Mok - Barclays Larry Solow - CJS Securities Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the RadNet, Inc. Fourth Quarter 2024 Financial Results Conference Call. All participants will be in a listen-only mode.
Charts implemented using Lightweight Charts™